All locations are open. Call your doctor today to schedule an in-person appointment or a doctor video visit.
Learn about our COVID-SAFE Care • Latest Visitor Policy and Service Updates • Donate and Lend Support


Todos los centros abiertos. Llame al médico hoy para una cita en persona o para una video visita médica.
Sepa qué es la Salud A SALVO DE COVID • Novedades de servicios y normas de visitas • Done y dé apoyo

Learn more
Espanol
Myelodysplastic Syndromes Research
Home >  Cancer (Oncology) >  Diseases and Conditions >  Myelodysplastic Syndromes (MDS) >  Myelodysplastic Syndromes Research
Print

Diseases and Conditions

Myelodysplastic Syndromes Research

Montefiore researchers are continually testing new treatments for MDS, and many of these studies originate at the Albert Einstein College of Medicine. These investigational approaches are offered to eligible patients here through the clinical trial process, which is designed to advance the current standard of care for MDS.

By treating patients with MDS in clinical trials, physicians have shown that 5-azacytidine, Decitabine, and Lenalidomide are safe and effective treatments for MDS. These clinical trials led to FDA approval of these drugs, and in this same way, we hope to develop even better treatments for MDS.

As with all cancer treatment, clinical trials involve a team approach, in which physicians, scientists, and pathologists work together to care for each patient. We are experts at determining which patients will derive the most benefit from which trial.

We invite you to use the clinical trials search tool below to find a clinical trial that suits your needs.